- Home
- EWBC vs PCVX Comparison
EWBC vs PCVX Comparison
Compare EWBC & PCVX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EWBC
- PCVX
- Stock Information
- Founded
- EWBC 1998
- PCVX 2013
- Country
- EWBC United States
- PCVX United States
- Employees
- EWBC N/A
- PCVX N/A
- Industry
- EWBC Major Banks
- PCVX Biotechnology: Pharmaceutical Preparations
- Sector
- EWBC Finance
- PCVX Health Care
- Exchange
- EWBC Nasdaq
- PCVX Nasdaq
- Market Cap
- EWBC 9.9B
- PCVX 9.6B
- IPO Year
- EWBC 1999
- PCVX 2020
- Fundamental
- Price
- EWBC $77.43
- PCVX $30.65
- Analyst Decision
- EWBC Buy
- PCVX Strong Buy
- Analyst Count
- EWBC 13
- PCVX 9
- Target Price
- EWBC $106.46
- PCVX $136.50
- AVG Volume (30 Days)
- EWBC 1.6M
- PCVX 3.7M
- Earning Date
- EWBC 04-22-2025
- PCVX 05-07-2025
- Dividend Yield
- EWBC 3.10%
- PCVX N/A
- EPS Growth
- EWBC 1.83
- PCVX N/A
- EPS
- EWBC 8.33
- PCVX N/A
- Revenue
- EWBC $2,385,692,000.00
- PCVX N/A
- Revenue This Year
- EWBC $5.34
- PCVX N/A
- Revenue Next Year
- EWBC $7.00
- PCVX N/A
- P/E Ratio
- EWBC $9.30
- PCVX N/A
- Revenue Growth
- EWBC 0.99
- PCVX N/A
- 52 Week Low
- EWBC $68.27
- PCVX $27.66
- 52 Week High
- EWBC $113.95
- PCVX $121.06
- Technical
- Relative Strength Index (RSI)
- EWBC 42.16
- PCVX 26.64
- Support Level
- EWBC $68.27
- PCVX $28.58
- Resistance Level
- EWBC $77.25
- PCVX $32.72
- Average True Range (ATR)
- EWBC 5.17
- PCVX 3.75
- MACD
- EWBC -0.04
- PCVX 0.12
- Stochastic Oscillator
- EWBC 36.68
- PCVX 29.09
About EWBC East West Bancorp Inc.
East West Bancorp Inc operates in U.S. and Asia. The Bank provides range of personal and commercial banking services to individuals and businesses. In addition to offering traditional deposit products that include personal and business checking and savings accounts, money market, and time deposits, the Bank also offers foreign exchange, treasury management and wealth management services. The Bank has three operating segments, (1) Consumer and Business Banking, (2) Commercial Banking and (3) Treasury and Other. The company generates the majority of its revenue from the Commercial banking segment.
About PCVX Vaxcyte Inc.
Vaxcyte Inc is a clinical-stage vaccine innovation company engineering high-fidelity vaccines to protect humankind from the consequences of bacterial diseases. It is developing broad-spectrum conjugate and novel protein vaccines to prevent or treat bacterial infectious diseases. Its product comprises of Pneumococcal conjugate vaccine. The firm's product candidate consists of VAX-31, VAX-24, VAX-A1, VAX-PG, VAX-GI, and Others.